Home / Feed item / OIRM: Relapse in patients with leukaemia (AML) caused by rare stem cells. New research from John Dick lab @UHN_Research http://ow.ly/drjs30d7han
OIRM: Relapse in patients with leukaemia (AML) caused by rare stem cells. New research from John Dick lab @UHN_Research http://ow.ly/drjs30d7han
Our Vision
OIRM will transform the treatment of incurable diseases, making Ontario a global leader in the development and dissemination and dissemination of stem cell-based products and therapies.